1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsIncludes AI-focused topics such as FALCON (Fusion of Abstract Learning and Context-Optimized Neural-methods) for LLMs and structured data reasoning, plus other advanced computing and AI topics under DARPA's SBIR program.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U. S. small businesses meeting SBIR eligibility criteria (for-profit, <500 employees, etc.). Confirm the full requirements in the official notice before applying.
The current listing shows typical SBIR Phase I amounts (around $250,000). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 19, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
DoD SBIR 2026 BAA | Release 4 is funded by Defense Advanced Research Projects Agency (DARPA). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Small Business Transition Grant for New Entrepreneurs (SBIR) — R43 Phase I is a grant from the National Institutes of Health (NIH) that funds early-stage scientific innovation by small businesses aiming to bring biomedical breakthroughs to the commercial marketplace. The Phase I award supports feasibility research, evaluating technical merit and commercial potential of proposed innovations. Eligible applicants are U.S. small business concerns, particularly new entrepreneurs, applying under PAR-24-131. Awards cover up to approximately $306,872 in total costs for Phase I. The most recent deadline is September 5, 2026.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). Operating under the NIH SBIR/STTR Solicitation 2026, the Commercialization Readiness Pilot program provides funding for high-value technical assistance and late-stage product development activities for small businesses that have completed a Phase II SBIR or STTR project.
DPA26BZ06-DV023 is a Direct-to-Phase-II SBIR paying $700,000 over 18 months plus a $500,000 option. The physics demands 256x more transmit power than the systems that qualify you to compete, and DARPA will not accept modeling alone as proof. Here is the eligibility wall, the five engineering problems, and who can realistically win it before the October 21 close.
Read articleRelease 6's SBIR topics got the attention. Its three STTR topics — SHIELDER, fuel-flexible electric propulsion, and hypersonic wind tunnel noise diagnostics — are all Direct-to-Phase-II, all require a research institution to perform at least 30 percent of the work, and all close October 21, 2026. The feasibility gates are the real filter.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read article